Skip to main content

Doherty Catherine T.'s Form 4 filing

Quest Diagnostics Inc (DGX) · filed Feb 17, 2026

Accession no.
0001022079-26-000009
Filed
Feb 17, 2026
Trade date
Feb 13, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.39M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Doherty Catherine T.CIK 0001520897Officer (EVP, Regional Businesses)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 13, 2026Common StockMOption exerciseAcquired+26,165$112.17+$2,934,928.0594,233Direct
Feb 13, 2026Common StockSSaleDisposed−10,573$205.21−$2,169,685.3383,660Direct
Feb 13, 2026Common StockSSaleDisposed−10,122$206.37−$2,088,877.1473,538Direct
Feb 13, 2026Common StockSSaleDisposed−3,500$207.08−$724,78070,038Direct
Feb 13, 2026Common StockSSaleDisposed−1,619$208.21−$337,091.9968,419Direct
Feb 13, 2026Common StockSSaleDisposed−351$209.10−$73,394.168,068Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 13, 2026Common StockMOption exerciseDisposed−26,165$112.17−$2,934,928.050Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)